Stay updated on Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The 'Last Update Posted' label on the Study Details page is now displayed as 'Last Update Posted (Estimated)', indicating the timestamp is approximate.
    Difference
    0.1%
    Check dated 2025-12-30T13:49:20.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Added Florida as a new study location under Locations, replacing the prior Florida Locations entry. Updated Last Update Posted to 2025-12 and revised the page to v3.3.3.
    Difference
    0.5%
    Check dated 2025-12-23T10:09:46.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.2.0 removed in the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:54:12.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Footer branding updates add 'Moffitt Cancer Center Clinical Trials website' and 'Helpful Links Provided by', and a government funding status notice was removed from the page.
    Difference
    0.6%
    Check dated 2025-11-17T17:49:36.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Core study details appear unchanged; no additions or deletions to the main study information were detected. The overall page structure and key fields such as title, conditions, interventions, outcomes, and eligibility remain the same.
    Difference
    0.4%
    Check dated 2025-11-03T12:32:43.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Summary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.
    Difference
    3%
    Check dated 2025-10-05T17:19:52.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page.